colleen, Author at Braeburn

21 Sep CAM2038 Receives Positive CHMP Opinion for the Treatment of Opioid Dependence in Europe

Posted at 11:23h in Press Release

Plymouth Meeting, PA—September 21, 2018 — Braeburn announces that Camurus has received a positive opinion from the European Medicines Agency’s...

18 Sep Braeburn Announces Positive Top-line Phase 3 Results for CAM2038 in Chronic Low Back Pain Patients Previously on Long-term Daily Opioid Therapy

Posted at 10:00h in Press Release

Plymouth Meeting, PA—September 18, 2018 — Braeburn announces positive top-line results for a Phase 3 study of CAM2038 for the...

17 Sep Celebrating Recovery Month

Posted at 16:02h in Culture

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]This past weekend, many on Team Braeburn participated in the Rock ‘n’ Roll...

31 Aug Honoring International Overdose Awareness Day

Posted at 07:00h in Culture

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Today is designated as International Overdose Awareness Day to raise awareness of overdose...

21 Aug Defining the Future: Summer 2018 Interns

Posted at 07:30h in Culture

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]This summer Braeburn was privileged to have 3 excellent interns work on our...

30 Jul Everything we think, say and do is with patients in mind.

Posted at 12:10h in Culture

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]At Braeburn, we have one mission: to help fight the opioid addiction epidemic. ...

16 Jul Working Toward a Common Goal: CAM2038 PDUFA

Posted at 13:26h in Culture

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]At Braeburn, we foster a team-oriented culture. Over the past few months, we...

16 Jul Braeburn Announces PDUFA Date for CAM2038 for the Treatment of Opioid Use Disorder

Posted at 08:00h in Press Release

If approved, CAM2038 will provide patients and HCPs with flexible-dose weekly and monthly options for the treatment of opioid use...

25 Jun Braeburn Appoints Richard Malamut, M.D. as Chief Medical Officer

Posted at 14:54h in Press Release

Plymouth Meeting, PA—June 25, 2018—Braeburn announces that Richard Malamut, M.D. has joined the company as Chief Medical Officer. Dr. Malamut...

25 Jun Braeburn’s New Corporate Headquarters

Posted at 14:52h in Culture

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Braeburn recently moved to a new corporate headquarters in Plymouth Meeting, Pa that...

Author: colleen